BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 23078246)

  • 21. Epstein-Barr Virus Latent Membrane Protein-1 Induces the Expression of SUMO-1 and SUMO-2/3 in LMP1-positive Lymphomas and Cells.
    Salahuddin S; Fath EK; Biel N; Ray A; Moss CR; Patel A; Patel S; Hilding L; Varn M; Ross T; Cramblet WT; Lowrey A; Pagano JS; Shackelford J; Bentz GL
    Sci Rep; 2019 Jan; 9(1):208. PubMed ID: 30659232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RNF111/Arkadia is a SUMO-targeted ubiquitin ligase that facilitates the DNA damage response.
    Poulsen SL; Hansen RK; Wagner SA; van Cuijk L; van Belle GJ; Streicher W; Wikström M; Choudhary C; Houtsmuller AB; Marteijn JA; Bekker-Jensen S; Mailand N
    J Cell Biol; 2013 Jun; 201(6):797-807. PubMed ID: 23751493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SUMO paralogue-specific functions revealed through systematic analysis of human knockout cell lines and gene expression data.
    Bouchard D; Wang W; Yang WC; He S; Garcia A; Matunis MJ
    Mol Biol Cell; 2021 Sep; 32(19):1849-1866. PubMed ID: 34232706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates.
    Gocke CB; Yu H; Kang J
    J Biol Chem; 2005 Feb; 280(6):5004-12. PubMed ID: 15561718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamin interacts with members of the sumoylation machinery.
    Mishra RK; Jatiani SS; Kumar A; Simhadri VR; Hosur RV; Mittal R
    J Biol Chem; 2004 Jul; 279(30):31445-54. PubMed ID: 15123615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small ubiquitin-like modifier (SUMO) isoforms and conjugation-independent function in DNA double-strand break repair pathways.
    Hu Y; Parvin JD
    J Biol Chem; 2014 Aug; 289(31):21289-95. PubMed ID: 24966330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sumoylation dynamics during keratinocyte differentiation.
    Deyrieux AF; Rosas-Acosta G; Ozbun MA; Wilson VG
    J Cell Sci; 2007 Jan; 120(Pt 1):125-36. PubMed ID: 17164289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SUMO-2/3 regulates topoisomerase II in mitosis.
    Azuma Y; Arnaoutov A; Dasso M
    J Cell Biol; 2003 Nov; 163(3):477-87. PubMed ID: 14597774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress.
    Morris JR; Boutell C; Keppler M; Densham R; Weekes D; Alamshah A; Butler L; Galanty Y; Pangon L; Kiuchi T; Ng T; Solomon E
    Nature; 2009 Dec; 462(7275):886-90. PubMed ID: 20016594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SUMOylation of Argonaute-2 regulates RNA interference activity.
    Josa-Prado F; Henley JM; Wilkinson KA
    Biochem Biophys Res Commun; 2015 Sep; 464(4):1066-1071. PubMed ID: 26188511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transient global cerebral ischemia induces a massive increase in protein sumoylation.
    Yang W; Sheng H; Warner DS; Paschen W
    J Cereb Blood Flow Metab; 2008 Feb; 28(2):269-79. PubMed ID: 17565359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SUMO1 negatively regulates reactive oxygen species production from NADPH oxidases.
    Pandey D; Chen F; Patel A; Wang CY; Dimitropoulou C; Patel VS; Rudic RD; Stepp DW; Fulton DJ
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1634-42. PubMed ID: 21527745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rap80 protein recruitment to DNA double-strand breaks requires binding to both small ubiquitin-like modifier (SUMO) and ubiquitin conjugates.
    Hu X; Paul A; Wang B
    J Biol Chem; 2012 Jul; 287(30):25510-9. PubMed ID: 22689573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a high-throughput screening assay for inhibitors of small ubiquitin-like modifier proteases.
    Yang W; Wang L; Paschen W
    J Biomol Screen; 2013 Jun; 18(5):621-8. PubMed ID: 23470489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modification of DBC1 by SUMO2/3 is crucial for p53-mediated apoptosis in response to DNA damage.
    Park JH; Lee SW; Yang SW; Yoo HM; Park JM; Seong MW; Ka SH; Oh KH; Jeon YJ; Chung CH
    Nat Commun; 2014 Nov; 5():5483. PubMed ID: 25406032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of small ubiquitin-like modifier substrates with diverse functions using the Xenopus egg extract system.
    Ma L; Aslanian A; Sun H; Jin M; Shi Y; Yates JR; Hunter T
    Mol Cell Proteomics; 2014 Jul; 13(7):1659-75. PubMed ID: 24797264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia.
    Carbia-Nagashima A; Gerez J; Perez-Castro C; Paez-Pereda M; Silberstein S; Stalla GK; Holsboer F; Arzt E
    Cell; 2007 Oct; 131(2):309-23. PubMed ID: 17956732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Ubc9, an E2 ligase for SUMO conjugation, with p53 is regulated by phosphorylation of p53.
    Lin JY; Ohshima T; Shimotohno K
    FEBS Lett; 2004 Aug; 573(1-3):15-8. PubMed ID: 15327968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SUMO: getting it on.
    Anckar J; Sistonen L
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1409-13. PubMed ID: 18031233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spatiotemporal distribution of SUMOylation components during mouse brain development.
    Hasegawa Y; Yoshida D; Nakamura Y; Sakakibara S
    J Comp Neurol; 2014 Sep; 522(13):3020-36. PubMed ID: 24639124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.